搶先第一個發表評論!

重點商品推薦

益處


TLS® 修身茶
•    有助抑制食慾
•    或有助增加飽肚感
•    促進健康的體重管理
•    支援代謝平衡與健康

TLS®高纖蛋白營養飲品 

•    優質的纖維、蛋白質與鈣質來源
•    恆常攝取足夠的鈣質及維他命D作為均衡飲食的一部分,或可減低患上骨質疏鬆症的風險。
•    攝取足夠的鈣與維他命D作為健康飲食的一部分,並配合運動,或可減低年長後患上骨質疏鬆症的風險。

Isotonix®基本營養組合包
Isotonix OPC-3®沖飲

  •  現今市場上最強效的抗氧化營養補充品!

Isotonix綜合維他命沖飲

  • 獲得全方位營養!

Isotonix全效維他命B群沖飲

  • 全面補充維他命B群

Isotonix鈣高效吸收沖飲

  • 維持骨骼強壯、牙齒與牙齦健康不可或缺的營養素

詳細資料


想要克服你的體重管理目標,大部份取決於你能否付諸行動,簡單地完成你已開始的計劃。在我們繁忙的生活中,下定決心開始一個計劃並持之以恆可能會很困難。TLS®最Fit組合包含由我們多種最有認受性的有效產品組合,助你在體重管理計劃的過程輕鬆保持健美體態而設計。此組合非常適合作為TLS 30日快速啟動組合的後續組合使用。

在組合裡,你能找到各種能幫助你的工具,例如能抑制食慾的產品、維持身體健康的主要維他命、抗氧化物及蛋白質。TLS修身茶是一種具有生熱作用的修身茶飲,能促進健康的體重管理。修身茶採用方便攜帶的獨立包裝,是一款適合外出時隨身攜帶的紅茶。TLS高纖蛋白營養飲品提供最理想的纖維、蛋白質來源及每食用量提供20種維他命及礦物質,多於「中國營養素參考值」的1/3** TLS高纖蛋白營養飲品不添加糖及含大量膳食纖維,適合成為你每日正餐之間能提供飽肚感且營養豐富的小吃。Isotonix基本營養組合包內含顧客最愛的Isotonix OPC-3®沖飲、Isotonix綜合維他命沖飲、Isotonix全效維他命B沖飲及Isotonix鈣高效吸收配方沖飲。一包簡單方便的Isotonix基本營養組合,即能為你身體提供每日必需的維他命、礦物質以及抗氧化物。

依指示使用這些產品可為你打穩健康基礎,支援你的代謝,達到成功管理體重的目的。透過TLS最Fit組合為你的身體充電,並達成你的目標。*


*此產品並不供作診斷、治療或預防任何疾病之用。

** 參考: Chinese Nutrition Reference Value, Centre for Food Safety, HKSAR http://www.cfs.gov.hk/english/programme/programme_nifl/files/HOWTOREAD_E.pdf

成份


TLS® 修身茶

紅茶萃取物(茶樹):700毫克
茶樹是一種能生產出各種茶葉的植物,包括紅茶、綠茶以及烏龍茶。各種茶的不同之處在於茶葉的發酵過程。經過完全發酵的茶葉能製成紅茶,部分發酵的茶葉能製成烏龍茶,而綠茶葉則是未經發酵。由於發酵過程不同,紅茶與綠茶所含有的化學成分亦不相同。

多酚類-例如生物類黃酮,包括兒茶素、茶紅素與茶黃素 - 大量存在於紅茶之中,被認為是紅茶眾多好處的來源。紅茶也含有單寧。*

WellTrim™iG (IGOB131®)非洲芒果(野生芒果)籽萃取物:300毫克
WellTrim iG是一種經臨床測試的非洲芒果萃取物,也被稱為野生芒果。非洲芒果樹普遍生長於非洲中部與西部。此植物成分是一款西非傳統烹飪用的水果核,其黏液(一種醣蛋白)可用來烹調傳統的湯。WellTrim iG是獲得專利許可與美國食藥署GRAS認證,經臨床測試的非洲芒果籽萃取物,適合用於減重與代謝健康。

非洲芒果跟甘油-3-磷酸脫氫酵素產生作用,從而減少脂肪儲存。透過調節這種酵素,能形成較少的脂肪,進而減少脂肪的儲存量。有兩篇人體臨床研究顯示非洲芒果對於特定功效,包括控制食慾、飽肚感、生熱作用、體重管理以及代謝健康。在這兩份研究中,體重管理與代謝健康皆有顯著的改善。*

WellTrim™ iG為Icon Group, LLC的商標。
IGOB131®為Gateway Health Alliances, Inc.的註冊商標,受到美國專利法保護,專利號碼7,537,790。

TLS®高纖蛋白營養飲品 

維他命A(棕櫚酸維他命A
維 他命A是脂溶性維他命。維他命A的來源包括器官肉類(例如肝臟和腎臟)、蛋黃、牛油、甘荀汁、南瓜、蕃薯、菠菜、桃、添加營養的奶類產品和鱈魚肝油。維他 命A是視黃醇、視黃醛和β-胡蘿蔔素等複合物家族的成員,身體組織需要維他命A促進整體生長和修護。維他命A促進健康的夜視力、支援正常骨骼生長、提供抗 氧化防護和支援免疫系統健康。

維他命
C(抗壞血酸)
維他命C來源包括椒類(甜椒、青椒、紅椒、紅辣椒和綠辣椒)、柑橘類水果、小椰菜、椰菜花、椰菜、芥蘭、綠葉甘藍、芥菜、西蘭花、菠菜、番石榴、奇異果、 黑加侖子及士多啤梨。堅果及穀類亦含有少量維他命C。需注意烹調會破壞維他命C的活性。維他命C對支援健康的免疫系統、促進心血管健康、協助維持健康的膽 固醇水平及提供抗氧化防護非常重要。人體無法自行製造或儲存維他命C,所以必須透過飲食和營養補充品攝取。

維他命
B1(硫胺)
硫胺於碳水化合物代謝及神經功能方面扮演重要角色。人體需要硫胺維持健康的神經系統,以及協助製造乙膽鹼和γ-氨基丁酸(GABA)兩種神經遞質。硫胺用於生產鹽酸,因此參與消化、有助提升能量及促進頭腦清晰。

維他命
B2(核黃素)
維他命B2存在於肝臟、奶類產品、深綠色蔬菜及部份海產中。維他命B2的角色是輔酵素,與其他維他命B合作。維他命B2促進血液健康,支援神經系統及人類正 常生長,並促進皮膚、指甲及頭髮健康生長,以及協助維持甲狀腺健康。維他命B2作為電子輸送鍊的一部份,能促進食物轉化成能量,在微觀的層面上推動細胞能 量。維他命B2有助脂肪分解,並作為輔因子,協助活化B6及葉酸。維他命B2為水溶性,除非是極微量,否則不會被儲存於體內,因此必須每日補充。於部份情 況下,維他命B2可作為抗氧化物。核黃素輔酶參與維他命B6和葉酸轉化至活性狀態的過程,以及色胺酸轉化至菸鹼酸的過程。

維他命
B3(菸鹼酸)
菸鹼酸是水溶性維他命,是健康、成長及繁殖多個方面所需的物質,亦是維他命B群的一部份。菸鹼酸有助消化系統、皮膚及神經的運作,同時對食物轉化成能量的過程非常重要。菸鹼酸存在於奶類產品、家禽、魚類、瘦肉、堅果、蛋、豆類及添加營養的麵包及穀類食品中。

維他命
B5(泛酸)
泛酸(維他命B5)是將膽鹼轉成乙膽鹼的轉化劑,乙膽鹼協助腦部正常的神經遞質活動。泛酸亦被認為是抗壓維他命,因為它能為腦部除毒,紓緩身體及情緒壓力,並在荷爾蒙分泌上擔當重要角色。


維他命
B12(鈷氨素) 
維 他命B12天然存在於肉類、肝臟、牛肉、豬肉、蛋、全脂奶、芝士、全麥麵包及魚類。維他命B12只能在動物產品裡找到,亦有少量提取自經發酵的大豆製品如 麵豉及天貝(Tempeh),以及花生。素食者需要服用維他命B12補充品,以維持最理想的健康。維他命B12進入人體後,會儲存於肝臟及其他組織留待日 後之用。B12的合成形態稱為鈷氨素,鈷氨素並非提取自動物或植物,而是維持正常運作人體細胞固有的物質,尤其是神經系統細胞(保護神經細胞)、骨髓及腸 道。這些組織會最先出現缺乏維他命B12徵狀。維他命B12於能量代謝過程角色重要,負責維持最高能量水平,而且是卓越的抗衰老成份,亦有助提高集中力。


葉 酸主要存在於水果和蔬菜。深綠葉蔬菜、橙、橙汁、豆類、豌豆和啤酒酵母都是維他命B群的豐富來源。在加強維他命B12的益處上,葉酸擔當重要的角色。這兩 種維他命B互相合作,以維持正常的紅血球細胞。葉酸協助胺基酸及蛋白質的正常使用,並促進合成DNA和RNA物質的正常製造。科學研究發現,維他命B12 與葉酸合作時,能促進健康的心血管及神經系統。


維他命
B6
維 他命B6的主要來源是家禽、魚類、全穀類和香蕉。維他命B6是蛋白質和胺基酸代謝的輔因子,並有助維持適當的體液平衡,以及協助維持健康的紅血球及白血球 細胞。製造血紅素需要維他命B6。維他命B6參與合成腦部及周邊神經細胞,建議用以提升腦部功能,尤其是改善情緒,維他命B6亦支援正常神經傳導。部份運 動補充品加入維他命B6,原因是其促進肝糖轉化成葡萄糖,以為肌肉提供能量。同時攝取維他命B6及葉酸顯示有助維持血漿內正常的同型半胱氨酸水平,能促進 心血管健康。維他命B6應該加入其他維他命B群,以達到最佳效果。

維他命
D3
大 多數人類主要透過規律的日曬獲得維他命 D。維他命D的食物來源包括添加維他命D的奶類(每杯含100國際單位)、鱈魚肝油和三文魚等含有大量脂肪的魚類。蛋黃和肝臟亦含有少量維他命D。維他命 D促進吸收鈣質和磷質,並支援製造多種參與鈣質吸收和儲存的蛋白質。維他命D與鈣質幫助骨骼維持堅固強健。維他命D促進鈣質由成骨細胞主動運輸至細胞外液 及腎臟,促進腎小管吸收鈣質及磷質。維他命D亦促進腸道上皮正常吸收鈣質及磷質,並促進組織健康生長和修護,支援整體皮膚健康。

維他命
E
維 他命E最佳的飲食來源包括蔬菜油、人造牛油、堅果、種籽、牛油果和小麥胚芽。紅花油富含維他命E,而粟米油和大豆油亦含少量維他命E。維他命E和生育醇 (tocopherol)與三烯生育醇(tocotrienol)同屬相關的複合物家族。很多節食人士都會留意進食脂肪的份量,通常他們攝取維他命E的份 量亦因減少進食高脂食物而較少。補充維他命E的主要健康好處來自其有助提升免疫力的抗氧化功能。維他命E 亦支援正常痊癒及促進心血管健康,是體內最強效的脂溶性抗氧化物之一。因此,維他命E保護細胞膜免於自由基傷害。

鈣質

鈣 質存在於奶類、芝士、乳酪、墨西哥粟米餅、大白菜、芥蘭和西蘭花。鈣質是重要的礦物質,具有很多生物功能。鈣質主要以氫氧基磷灰石 (hydroxyapatite,Ca10 (PO4)6 (OH)2)的形式存在於骨骼之中。氫氧基磷灰石大約佔骨骼重量40%。骨骼明顯需要補充鈣質,而且骨骼也是鈣質的儲藏室。鈣質除了是骨骼和牙齒的主要組 成物外,亦能夠促進正常肌肉收縮、神經傳導、心血管健康、能量製造和維持健康的免疫系統。

鈣質對於維持骨骼密度及健康的骨骼與牙 齒非常重要。研究顯示,鈣質能紓緩女性經前綜合症引起的徵狀。若人體每日吸收的鈣質不足,就會從骨骼提取鈣來使用,令骨質流失,引致骨質疏鬆症。骨質疏鬆 症由因年齡增長而導致骨質流失引起,可增加盆骨、胸骨、骨盆及其他脆弱骨骼骨折的風險。另外,隨年齡增長,脊骨累積輕微骨裂,導致駝背,這亦可能引致骨折。

血液中鈣質的含量由PTH(副甲狀腺荷爾蒙)調節。高鈣質含量與維持更年期女士的心血管健康及維持正常膽固醇有關,而低鈣質含量則與骨質密度下降和骨質疏鬆症有關。


鉻 天然存在於部份穀物、肉類、家禽、啤酒酵母、西蘭花、梅乾、菇類、魚類及啤酒。鉻是必要的微量礦物質,能促進正常的葡萄糖代謝、調節胰島素水平,並有助人 體維持健康的血膽固醇及其他脂肪水平。鉻結合構成耐糖因子(GTF),促進正常胰島素活動,調節血糖水平。研究顯示,鉻有助減少整體脂肪、控制飢餓感及抑 制食慾。在減重行業,很多人將鉻視為體重控制不可或缺的礦物質。鉻亦可能有助增加肌肉。


含最豐富銅含量的食物來源包括內臟、海產、堅果、種籽、小麥麩皮穀類、全麥製品及可可製品。銅可能具抗氧化功效,並組成參與鐵代謝過程的酶。銅是必要的微量礦物質,對正常嬰兒發展、鐵的運輸過程、骨骼強度、膽固醇代謝、心肌收縮、葡萄糖代謝、腦部發展及免疫功能非常重要。


碘存在於大部份海產及加碘食鹽。碘為甲狀腺荷爾蒙的必要組成部份,有助調節及維持正常代謝運作。


富 含鎂的食物包括未經打磨的穀物、堅果及綠色蔬菜。綠葉蔬菜含高葉綠素含量,因此是鎂的豐富來源。肉類、澱粉質及奶類產品的鎂含量較低。精製及加工食品的鎂 含量亦普遍較少。鎂是骨頭內礦物質部份的其中一種成份,能支援成年人鉀及鈣的代謝作用。鎂有助維持正常的鉀、磷、鈣、腎上腺素及胰島素水平。鎂亦支援鈣傳 送至細胞內的過程,以供人體使用。鎂促進肌肉及神經組織的正常功能,以及蛋白質、核酸、核甘酸、環腺單磷酸、脂質及碳水化合物的合成。

鎂促進能量釋放、正常體溫調節及神經功 能、亦有助應付壓力及促進健康的代謝作用。鎂與鈣互相合作,促進正常調節心臟及血壓。很重要的是,鎂還支援人體發展健康骨骼、牙齒及肌肉。鎂與鈣及維他命 D互相合作,有助維持骨骼強壯。鎂亦支援血小板正常活動及協助維持正常膽固醇水平,促進心血管健康。


錳是大量存在於植物及動物物質內的礦物質。含錳最富豐的食物來源包括全穀物、堅果、有葉蔬菜及茶。含錳濃度最高的是穀物的穀糠部份,但穀糠通常會在穀物加工時被去除。錳通常以葡萄糖酸錳、錳硫酸鹽、錳抗壞血酸及錳氨基酸複合物的形式出現。

人體組織只含有微量的錳元素,主要儲存於骨頭、肝臟、腎臟及胰臟。錳支援正常的結締組織、骨骼、凝血因子及性荷爾蒙的形成。此外,錳還支援正常的脂肪及碳水化合物代謝作用、鈣質吸收及血糖調節,並促進正常的腦部及神經功能。


富 含鉀的食物來源包括香蕉、橙、哈蜜瓜、牛油果、沙律用菠菜、椰菜及芹菜等新鮮蔬菜及水果。鉀是必要的主要礦物質,有助維持液體平衡,同時參與多種生化及生 理過程。除此之外,鉀還支援正常的神經脈衝傳導,心臟肌肉、骨骼肌肉及平滑肌肉的收縮、能量產生、核酸合成、維持細胞內壓力以及維持正常血壓。鉀支援正常 的肌肉舒張及胰島素釋放,並促進肝糖及蛋白質的合成。此外,鉀是促進正常心跳的電解質,而且在代謝作用中從蛋白質、脂肪及碳水化合物釋放能量擔當重要角 色。

鉀還支援人體調節水平衡、運動後復原及排泄廢物的能力。鉀促進正常痊癒及整體健康。鉀儲存於肌肉。


硒 的最佳食物來源包括堅果、未加工穀類、糙米、小麥胚芽和海產。於人體內,硒的功能為作為抗氧化酶谷胱甘肽過氧化物酶的部份,以及促進正常生長及碘於甲狀腺 功能的正常運作。硒亦支援維他命E的抗氧化功效,普遍加入維他命E補充品。作為抗氧化物谷胱甘肽過氧化物酶的一部份,硒對人體保護細胞免受自由基傷害有直 接影響。


富 含鋅的食物包括添加營養的穀類食品、紅肉、蛋類、家禽和蠔等海產。鋅是多種酶及蛋白質的組成物,參與調節基因表現。鋅是必要的微量礦物質,參與約三百種不 同酶的反應。因此,鋅支援幾乎所有生化路徑和生理過程。體內超過90%的鋅都儲存於骨骼和肌肉,但是幾乎所有的身體組織都存在鋅。有指鋅支援正常痊癒及免 疫系統、促進健康前列腺及支援健康精子質量。由於鋅參與多種酶過程,其支援多種功能,包括消化、能量生產、生長、細胞修復、膠原合成、強化骨骼、認知功能 及碳水化合物代謝。

生物素
生 物素的食物來源為蛋黃、花生、牛肝、奶類(每杯10微克)、穀類、杏仁及啤酒酵母。生物素用於健康的細胞生長、脂肪酸的製造、脂肪及氨基酸代謝作用。生物 素在檸檬酸循環中擔當重要角色,檸檬酸循環是有氧呼吸中產生生化能量的過程。生物素不單協助多種化學物質代謝轉化過程,還有助輸送二氧化碳。生物素有助維 持穩定血糖水平。生物素亦被建議用作增強頭髮及指甲之用。

乳清蛋白

蛋白質不會令血糖急升,並有助你感到飽足。蛋白質於維持及建立肌肉以輕易進行一般工作亦非常重要。蛋白質植物來源(例如大豆)並不含有大量飽和脂肪,因此較動物來源可取。

Fibersol-2
(水溶性纖維葡萄糖聚合物複合物)
Fibersol- 2是一種水溶性纖維,對消除廢物及腸道清洗有正面的效果,並有助維持平衡腸道菌叢、有助支援正常排便規律及排便量,以及支援健康消化功能。 Fibersol-2是透過粟米粉高溫分解及穩定酵素水解而製成的噴霧風乾粉末,為被美國食品藥物主管機構評為安全(普遍認為安全)的麥芽糊精,易溶於水 中,而且不含任何味道。Fibersol-2的黏性低、水溶性高,以及吸水度低,溶於水中成為清澈的溶液。Fibersol-2天然含有大量不會於消化道 內被消化的化學鍵,因此有助維持正常膽固醇及血糖水平,並促進免疫健康,有助支援整體健康。


Isotonix®基本營養組合包

葡萄籽萃取物
葡萄籽萃取物一般提取自紅葡萄(而非白葡萄)的籽,含有大量稱為原花色素(OPC)的複合物,以及具抗氧化功效的多酚類。葡萄籽富含具強效抗氧化功效的多酚類複合物。

紅酒萃取物
紅酒萃取物是強效抗氧化物,存在於葡萄的藤、根、籽及莖中,葡萄皮中的含量最高。紅酒萃取物的抗氧化特質能鞏固微血管、動脈和靜脈,有助維持健康的血液循環和提升整體心血管健康。

90年代末,科學家注意到法國人的一個現象。某些省份的人進食較高脂肪的食物並同時飲用紅酒,而從古至今這些人患有心臟問題的比率非常低。科學家得出結論:紅酒所具有的保護特性多年來幫助法國人維持心臟健康。後續的科學研究更進一步證實,紅酒中所含的OPCs對維護心臟和血管的健康大為有益。

松樹皮萃取物(碧容健®,Pycnogenol®)碧容健® (Pycnogenol®)是由海岸松樹皮萃取的天然植物萃取物,這種海岸松樹只生長在法國西南部沿岸的加斯科尼地區。這片不受污染的天然樹林就是碧容健®的唯一來源。碧容健®是天然產品巿場上,最受廣泛研究的成分之一。發表的研究報告顯示,碧容健®對身體健康有許多好處。松樹皮萃取物結合全天然原花青素、生物類黃酮及有機酸。

此萃取物擁有三項基本特質:抗氧化、選擇性結合膠原蛋白及彈力蛋白,以及協助內皮細胞製造一氧化氮,一氧化氮能促進血管的正常舒張。
碧容健®作為最強效、天然的自由基對抗物,能去除所有具侵略性的自由基,使自由基不能藉著氧化壓力損害人體。碧容健®的強超抗氧化能力有助支援健康的血小板活動,緩解輕度經痛與腹痛,維持關節靈活,促進心血管健康,並支援健康膚色。

歐洲藍莓萃取物
來自一種普遍歐洲常見的矮灌木,取其葉子與像莓子的果實,這種矮灌木是藍莓的非常近似。成熟的歐洲藍莓萃取物含有稱為花青素的類黃酮色素,是強效的抗氧化物。科學研究證明,歐洲藍莓有助支援健康的視力及靜脈血液循環,歐洲藍莓萃取物能鞏固微血管、動脈和靜脈,有助維持健康的血液循環。

柑橘類萃取物(生物類黃酮)
生物類黃酮是存在於部份植物的抗氧化物,也是吸收紫外線輻射的光線過濾器,保護容易受損的DNA鍊以及其他重要的大分子。現已發現生物類黃酮能改善心血管健康,具有抗炎作用,同時鞏固微血管、動脈和靜脈,繼而維持良好的血液循環。

維他命A(β-胡蘿蔔素/維他命A前導物)維他命A為脂溶性維他命。維他命的來源包括動物內臟(如肝臟和腎臟)、蛋黃、牛油、紅蘿蔔汁、南瓜、番薯、菠菜、桃、強化奶製品和鱈魚肝油。維他命A屬於視黃醇、視黃醛和β-胡蘿蔔素等複合物家族。β-胡蘿蔔素亦是維他命A原,當身體有額外需求時,便會轉化成維他命A。維他命A提供全身組織的正常發育及修護。維他命A能促進良好的夜視能力,支援正常的骨骼成長,協助抗氧化防禦,並支援健康的免疫系統。

維他命C(抗壞血酸) 
維他命C存在於椒類(甜椒、青椒、紅椒、紅辣椒及青辣椒)、柑橘類水果、結球甘藍、椰菜花、椰菜、羽衣甘藍、芥蘭、芥菜、西蘭花、菠菜、番石榴、奇異果、黑加侖及士多啤梨等。堅果類及穀類亦含有微量的維他命C,維他命C的活性很容易因烹煮而受損。
維他命C支援健康的免疫系統,促進心血管健康,並且提供抗氧化功能。人體無法自行製造及儲存維他命C。因此,維他命C必須透過飲食和營養補充品而取得。

硫胺素(維他命B1)
硫胺素對碳水化合物的正常代謝,和維持健全的神經系統扮演重要的角色。健康的神經系統需要硫胺素,協助製造神經傳導物質乙醯膽鹼和γ-胺基丁酸(GABA)。

泛酸(維他命B5)
泛酸(B5) 是幫助膽鹼轉化為乙酰膽鹼的轉換器。乙酰膽鹼有助維持正常的大腦神經傳導活動。

菸鹼酸(維他命B3)
維他命B3是水溶性的維他命,對健康、生長和生殖的許多層面來說都是必需的。它是維他命B群之一。菸鹼酸幫助維持正常的消化系統,以及皮膚和神經的運作。同時也有助轉化食物為能量。菸鹼酸(一般又稱為維他命B3)多存在於奶類製品、家禽、魚類、瘦肉、堅果、蛋、豆類、營養強化麵包以及早餐穀類中。

維他命B12(氰鈷胺)
維他命B12天然存在於在肉類、肝臟、牛肉、豬肉、蛋類、全脂牛奶、乳酪、全麥麵包和魚類中。維他命B12主要只能從動物製品中獲得,另外有少量來自發酵豆類製品,例如味噌、豆豉及花生。素食者必須使用維他命B12補充品以維持最佳的健康狀態。維他命B12在攝取後儲存於肝臟和其他組織內,以供日後使用。合成的維他命B12,又稱氰鈷胺,是無法由植物或動物本身萃取,對於維護細胞正常功能有著舉足輕重的影響力。這些組織會率先顯示出維他命B12不足的跡象。維他命B12本身負責維持最佳能量水平,因為它在克氏循環(Krebs energy cycle)中扮演關鍵角色。維他命B12同時也是一種重要的抗衰老元素,並有助集中注意力。

葉酸
葉酸主要存在於蔬果中。深綠色蔬菜、橙、橙汁、豆類、豌豆和啤酒酵母是提供葉酸的最佳來源。葉酸在提升B12補充品效用方面擔當關鍵的角色。這兩種維他命B協力合作,維護正常的紅血球細胞。葉酸有助氨基酸及蛋白質的正常使用,並促進製造脫氧核糖核酸DNA與核糖核酸RNA物質的合成,是身體所有功能必需的。科學研究發現當維他命B12與葉酸一起運作時,能支援正常的半胱胺酸水平。這有助支持健康的心血管與神經系統。

核黃素-5-磷酸鹽 (維他命B2)
維他命B2存在於肝臟、奶類製品、深綠色蔬菜和某些種類的海鮮。維他命B2是一種輔酵素,和其他的維他命B產生協同作用。維他命B2促進血液和神經系統的健康,以及正常人體生長。它可支援皮膚、指甲和頭髮的健康生長。維他命B2在食物轉換為能量的過程中扮演關鍵的角色,是電子傳送鏈的一部分,能給予細胞能量。維他命B2用作於激活維他命B6和葉酸同時,有助分解脂肪。維他命B2為水溶性,除非攝取量非常不足,否則無法儲存於人體內,因此必須每日補充。在某些情況下,維他命B2可作為抗氧化物。核糖黄素輔酶有助轉化維他命B6及葉酸的活性,同時幫助色胺酸轉化為菸鹼酸。

鹽酸吡哆辛(維他命B6)
維他命B6的主要來源是家禽、魚類、全穀類和香蕉。維他命B6是一種輔酵素,參與蛋白質和胺基酸的代謝轉化,並且幫助維持體液平衡,維他命B6有助維護健康的紅血球和白血球細胞。維他命B6參與血紅蛋白的合成。它參與腦和周圍神經細胞中神經遞質的合成,它被推薦作為一種營養素來增強心理功能,特別是情緒,並支援正常的神經傳導。維他命B6與葉酸一起食用時,已被證明有幫助維持同型半胱氨酸的正常血漿水平,從而促進心血管的健康。

維他命D3 (膽鈣化醇) 
大多數人主要從太陽光中獲取維他命D。維他命D的飲食來源包括添加維他命D的牛奶(每杯含100 IU國際單位)、鱈魚肝油及富含脂肪的魚類,例如三文魚。蛋黃和肝臟含有少量的維他命D。維他命D能幫助吸收鈣質和磷,並協助製造幾種有助於鈣質吸收和儲存的蛋白質。維他命D與鈣兩者共同促進骨骼強壯。它能協助將骨細胞中的鈣質,運送至細胞外液和腎臟,促進腎小管順利吸收磷和鈣。維他命D有助腸道壁表面細胞正常吸收從飲食中攝取的鈣和磷。它促進組織健康生長及修護,並且維護皮膚的整體健康。

維他命E(d-α-生育醇琥珀酸酯)
維他命E重要的飲食來源包括蔬菜油、人造牛油、果仁、種籽、牛油果和小麥胚芽。紅花油富含大量的維他命E (¼杯中就約有⅔的每日建議攝取量),而粟栗米油和大豆油中僅含有微量。維他命 E 和生育醇 (tocopherols) 與三烯生育醇 (tocotrienols) 同屬相關的複合物家族 維他命 E有天然或合成形式。絕大多數時,天然形式和合成形式都是一樣,但天然形式的維他命E較能在體內吸收及留存。天然形式的α生育醇又被稱為d-α生育醇 (天然形式存在於Isotonix綜合維他命沖飲中)。合成形式dl-最常見於膳食補充品。在執行體重管理的人通常會注重飲食中脂肪的攝取量,他們由於減少攝取脂肪含量較高的食物,因此有可能也減少維他命E的攝取。
維他命E主要的功能在於它可促進免疫功能的抗氧化活動。維他命E亦能支援正常的癒合,並且促進心血管健康。維他命E是體內最有效的脂溶性抗氧化物之一。維他命E更能保護細胞膜免受自由基的傷害。

鈣(乳酸,磷酸鹽)
鈣質存在於牛奶、芝士、乳酪、墨西哥玉米餅、大白菜、羽衣甘藍和西蘭花中。鈣質是重要的礦物質,具有多項生物功能。鈣質主要以氫氧基磷灰石的形式,Ca10 (PO4)6 (OH)2,存在於骨骼之中。氫氧基磷灰石大約佔骨骼重量40%。骨骼是主要需要補充鈣質的人體結構,而且骨骼也是鈣質的儲藏室。鈣質是構建骨骼與牙齒的,同時促進正常的肌肉收縮、神經傳導及心血管健康,有助製造能量和維持健康的免疫系統。

要維持骨質密度及健康的牙齒與骨骼,每天必須補充足夠的鈣質。鈣質顯示能紓緩婦女的更年期症狀。若沒有每日攝取足夠的鈣質,身體會從骨骼中吸取鈣質,進而造成骨質流失和骨質疏鬆。骨質疏鬆是和年紀相關的骨質流失現象,可能導致危險的髖關節、肋骨、骨盆、以及其它衰老部位的骨頭斷裂。除骨質疏鬆外,高齡也會導致因為脊椎小部位的斷裂,慢慢累積而成的彎腰駝背。

鉻 (肌醇) 
鉻天然存在於某些穀類、肉類、家禽類、啤酒酵母、西蘭花、西梅、菇類、魚類及啤酒。鉻已被證明有助於減少體內脂肪,控制飢餓感並抑制食慾。許多體重管理行業的人認為鉻是控制體重的重要礦物質。鉻也可能幫助身體結實和增加肌肉。

銅(葡萄糖酸鈣)
 銅的最佳飲食來源是內臟、海鮮、堅果、種籽、小麥麩皮穀類、全麥製品、以及可可類產品。銅或具抗氧化功效,同時在鐵的代謝過程中扮演酵素成分的角色。銅是一種是很重要的微量礦物質。銅對於正常嬰兒發展、鐵質輸送、骨骼強度、心肌收縮、大腦發育及免疫功能,都是必須的。

碘(碘化鉀) 
碘存在於大部分的海鮮及加碘食鹽。它有助於調節和維持正常的新陳代謝運作。

鎂(碳酸鹽)
富含鎂的食物包括未經打磨的穀物、果仁和綠色蔬菜。綠色葉菜類是鎂的豐富來源,因為其中含有葉綠素。肉類、澱粉類和牛奶中的鎂含量較少。精製加工食物一般鎂含量都相當低。鎂是協助骨骼礦物化的元素之一,是成人代謝鉀和鈣所不可或缺的成分。有助維持體內鉀、磷及鈣的含量於正常水平。對鈣的調動也十分重要,將鈣運輸到細胞內以便進一步運用。它在肌肉和神經組織的功能中起著關鍵作用。鎂是合成所有蛋白質、核酸、核苷酸、環腺苷酸一磷酸、脂質及碳水化合物所必需的。

鎂是釋放能量所必需的,並促進體溫的正常調節及適當的神經功能,協助身體處理壓力,並且促進正常的新陳代謝。重要的是,身體也需要鎂來建立健康的骨骼和牙齒,促進肌肉的正常發展。鎂、鈣及維他命D一起使用,有助維持骨骼強壯。鎂能促進心血管健康。

錳(葡萄糖酸鈣)
錳是一種大量存在於植物和動物裡的礦物質。富含錳的食物來源包括全穀類、堅果、葉菜和茶。含錳濃度最高的是穀物的穀皮部份,但通常穀物在加工時,穀皮都會被去除。錳有多種不同的形式存在營養補充品中,包括葡萄糖酸錳、硫酸錳、抗壞血酸錳、氨基酸螯合錳等。
人體組織內僅含有微量的錳。錳主要儲存於骨骼、肝臟、腎臟和胰臟。它支援結締組織、骨骼及血液凝固因子的正常形成。它促進正常脂肪和碳水化合物的代謝,有助鈣質吸收,錳亦有助促進正常的大腦及神經功能。

鉀 (碳酸氫)
(碳酸氫鈉)富含鉀的食物包括了新鮮蔬果,例如香蕉、橙、哈蜜瓜、牛油果、生菠菜、椰菜及芹菜。鉀是幫助維持體液平衡的必要宏量礦物質。它還在各種生化和生理過程中發揮作用。此外,它還支援正常的神經脈衝,心臟、骨骼肌及平滑肌的收縮,製造能量,合成核酸,以及有助於維持細胞內滲透壓和血壓。鉀有助正常的肌肉放鬆,亦促進蛋白質的合成。鉀是一種電解質,促進正常心跳功能。鉀對於蛋白質、脂肪,與碳水化合物在代謝過程中的能量釋放也很重要。

鉀還有助於調節水分平衡,並有助恢復體力。鉀支援正常廢物清除。鉀促進正常的癒合,一般有助於提升身體健康感。鉀儲存於肌肉內。

硒(氨基酸螯合物)
硒的最佳飲食來源包括堅果、未加工穀類、糙米、小麥胚芽和海鮮。硒有助維他命E的抗氧化功效,也常被加入維他命E營養補充品內。作為抗氧化物,穀胱甘肽過氧化物酵素中的一部分,硒可直接保護細胞免受自由基的損害。

鋅(乳酸) 

鋅大量存在於營養強化的穀類、紅肉、蛋、家禽和蠔等海鮮中。鋅是多種酵素和蛋白質的組成物。與基因表現的調節有關。鋅是一種必要的微量礦物質,參與三百多種不同的酵素反應。因此,鋅支援幾乎所有的生物化學途徑和生過程中起作用。體內90%以上的鋅都儲存於骨骼和肌肉中,但是幾乎在所有的身體組織都含有鋅。據稱鋅支援正常的癒合和免疫系統。

生物素

含有生物素(維他命B7)的食物包括蛋黃,花生,牛肝,牛奶(10微克/杯),早餐穀類,杏仁以及啤酒酵母。生物素有助維持細胞的健康成長,脂肪酸的製造,以及脂肪和氨基酸的代謝。它在檸檬酸循環中起作用,檸檬酸循環是在有氧呼吸過程中產生生化能量的過程。生物素不僅有助於各種代謝化學的轉化,同時也有助於二氧化碳的轉移。生物素通常被推薦用於強化頭髮和指甲。

常見問答


哪些人適合使用TLS®最Fit組合?
此組合適合任何年滿18歲或以上、剛剛完成TLS 30日快速啟動計劃,或正在尋找一套經濟有效及全面的減重計劃的人士。全面的組合能促進最佳身體組成並解決有效體重管理的基本要求。無論你是完成TLS 30日快速啟動組合後需要一個理想的後續計劃,或只想要一個組合幫助你塑身與減重,TLS最Fit組合絕對合適不過。*

該如何使用TLS修身茶?
將一包分量加入6安士(約180毫升)的熱水或冷水,拌勻。於餐前30-60分鐘飲用,以獲得最佳效果,但亦可於其他時候飲用。可以按個人喜好,加入較多或較少分量的水。

TLS高纖蛋白營養飲品如何幫助減重?

TLS高纖蛋白營養飲品提供優質的蛋白質來源,促進飽肚感,幫助你遠離垃圾食物。

為甚麼我需要食用綜合維他命?
優質的維他命及礦物質營養補充品,能為均衡飲食帶來完整的微量營養素基礎。維他命及礦物質有助於支援免疫系統,促進食物轉化為能量,維持健康的心血管系統,促進骨骼強壯,有助維持正常的新陳代謝,促進健康發育及組織修護。

為何Isotonix營養補充品較其他產品優勝?

Isotonix的配方遠較其他普通營養補充品有效,因為其配方能有效地將維他命、礦物質和營養素輸送到血液中。當使用Isotonix系列時,由於產品的酸鹼值與強度皆經精心設計,胃部幾乎不須處理即可將所有的營養素釋放到小腸中。*

我一定要運動才有成效嗎? 

這些產品需要搭配健康的飲食與運動,才能發揮最大的效果。透過適當的營養吸收及運動,能持續穩定地減去體脂並增加肌肉,這方法被證實能達成體重管理及健身的目標。

使用TLS 最Fit組合安全嗎? 

此產品安全且不含有害物質、防腐劑及酒精。此產品在美國製造,並由經美國食品及藥物管理局檢測的設備生產,符合良好生產規範。顧客可信賴本產品的質量和安全。

科學


TLS® Trim Tea

  • Bray G and York D. Clinical review 90: Leptin and clinical medicine: a new piece in the puzzle of obesity. Journal of Clinical Endocrinology and Metabolism. 82(9):2771-6, 1997.
  • Cohen P, et al. Selective deletion of leptin receptor in neurons leads to obesity. Journal of Clinical Investigation. 108(8):1113-21, 2001. 
  • Flegal K et al. Prevalence and trends in obesity among US adults, 1999-2008. JAMA. 303(3):235-241, 2010.
  • Friedman JM. The function of leptin in nutrition, weight, and physiology. Nutrition Reviews. 60(10 Pt 2):S1-14; discussion S68-84, 85-7, 2002. Review.
  • Gil-Campos M, et al. Adiponectin, the missing link in insulin resistance and obesity. Clinical Nutrition. 23(5):963-74, 2004. Review.
  • Hasani-Ranjbar S1, Jouyandeh Z, Abdollahi M. A systematic review of anti-obesity medicinal plants - an update. J Diabetes Metab Disord. 19;12(1):28, 2013. 
  • Hodgson JM, Puddey IB, Croft KD, et al. Acute effects of ingestion of black and green tea on lipoprotein oxidation. Am J Clin Nutr. 71:1103-7, 2000.
  • Kubota K et al. Improvements of mean body mass index and body weight in preobese and overweight Japanese adults with black Chinese tea (Pu-Erh) water extract. Nutr Res. 31(6):421-8, 2011.
  • Ngondi J et al. Effect of Irvingia gabonensis kernel oil on blood and liver lipids on lean and overweight rats. Journal of Food Technology. 3:592-4, 2005. 
  • Ngondi J et al. IGOB131, a novel seed extract of the West African plant Irvingia gabonensis, significantly reduces body weight and improves metabolic parameters in overweight humans in a randomized double-blind placebo controlled investigation. Lipids in Health and Disease. 8:1-7, 2009. 
  • Ngondi J et al. The effect of Irvingia gabonensis seeds on body weight and blood lipids of obese subjects in Cameroon. Lipids in Health and Disease. 4:12, 2005. 
  • Oben J et al. Inhibition of adipogenesis by Irvingia gabonensis seed extract (IGOB131) as mediated via down regulation of the PPAR gamma and leptin genes, and up-regulation of the adiponectin gene. Lipids in Health and Disease. 7(1):44, 2008. 
  • Oben J et al. Irvingia gabonensis on body weight and bloods lipids in normolipidemic guinea pigs. Journal of Food Technology. 3: 472-474, 2005. 
  • Qi Y et al. Adiponectin acts in the brain to decrease body weight. Nature Medicine. 10(5):524-9, 2004. 
  • Sinha M. Evidence of free and bound leptin in human circulation. Studies in lean and obese subjects and during short-term fasting. Journal of Clinical Investigation. 98(6):1277-82, 1996. 
  • Swierczynski J et al. Enhanced glycerol 3-phosphate dehydrogenase activity in adipose tissue of obese humans. Molecular and Cellular Biochemistry. 254(1-2):55-9, 2003. 
  • Vinson JA, Teufel K, Wu N. Green and black teas inhibit atherosclerosis by lipid, antioxidant, and fibrinolytic mechanisms. J Agric Food Chem. 52:3661-5, 2004.


TLS® Nutrition Shake

  • Blomstrand E, et al, Branched-chain amino acids activate key enzymes in protein synthesis after physical exercise. J Nutr 136, (1 Suppl): 269S-73S (2006)
  • Burke, G, et al, The effect of whey protein supplementation with and without creatine monohydrate combined with resistance training on lean tissue mass and muscle strength. Int J Sport Nutr Exerc Metab 11, 3:349-64 (2001)
  • Meunier PJ. Calcium, vitamin D and vitamin K in the prevention of fractures due to osteoporosis. Osteoporos Int. 1999;9 Suppl 2:S48-52.
  • Miller ER 3rd, Appel LJ, Levander OA, Levine DM. The effect of antioxidant vitamin supplementation on traditional cardiovascular risk factors. J Cardiovasc Risk. 1997 Feb;4(1):19-24.
  • Nielsen FH. Ultratrace minerals. In: Shils ME, Olson JA, Shike M, Ross AC, eds. Modern Nutrition in Health and Disease, 9th ed. Baltimore, MD: Williams and Wilkins; 1999:283-303.
  • Nishi Y. Anemia and zinc deficiency in the athlete. J Am Coll Nutr. 1996 Aug;15(4):323-4.
  • Ohtani M, et al, Amino acid mixture improves training efficiency in athletes. J Nutr 136, 2:538S-543S (2006)
  • Rennie MJ, et al, Branched-chain amino acids as fuel and anabolic signals in human muscle. J Nutr 136, (1 Suppl): 264S-8S (2006)
  • Shimomura Y, et al, Exercise promotes BCAA catabolism: effects of BCAA supplementation on skeletal muscle during exercise. J Nutr 134, (6 Suppl): 1583S-1587S (2004)
  • Tipton KD, et al, Ingestion of casein and whey proteins result in muscle anabolism after resistance exercise. Med Sci Sports Exerc 36, 12:2073-81 (2004)
  • Tokunaga K and Matsuoka A, Effects of a [FOSHU] which contains indigestible dextrin as an effective ingredient on glucose and lipid metabolism," J Japanese Diabetes Society , 42:61-65, 1999.)


Isotonix® Daily Essentials Packets

Isotonix OPC-3®

  • Bayeta, E., et al. Pycnogenol inhibits generation of inflammatory mediators in macrophages. Nutrition Research 20: 249-259, 2000.
  • Blazsó, G., et al. Anti-inflammatory and superoxide radical scavenging activities of a procyanidins containing extract from the bark of Pinus pinaster Sol. and its fractions. Pharm Pharmacol Lett 3: 217-20, 1994
  • Cesarone, M., et al. Improvement in Circulation and in Cardiovascular Risk Factors With a Proprietary Isotonic Bioflavanoid Formula OPC-3OPC-3. Journal Angiology 59: 408-414, 2008.
  • Cho, K., et al. Effect of bioflavonoids extracted from the bark of Pinus maritima on proinflammatory cytokine interlukin-1 production in lipopolysaccharide-stimulated RAW 264. 7. Toxicology and Applied Pharmacology 168: 64-71, 2000.
  • Cho, K., et al. Inhibition mechanisms of bioflavonoids extracted from the bark of Pinus maritima on the expression of proinflammatory cytokines. Annals of the NYAcademy of Sciences 928: 141-156, 2001.
  • Devaraj, S., et al. Supplementation with a pine bark extract rich in polyphenols increases plasma antioxidant capacity and alters the plasma lipoprotein profile. Lipids 37:931-4, 2002.
  • Fine, AM, Oligomeric proanthocyanidin complexes: history, structure, and phytopharmaceutical applications. Altern Med Rev 5:144-51, 2000.
  • Fitzpatrick, D., et al. Endothelium-dependent vascular effects of Pycnogenol. Journal of Cardiovascular Pharmacology 32: 509-515, 1998.
  • Frankel, E., et al. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet 341: 454-7, 1993.
  • Freedman, J., et al. Select flavonoids and whole juice from purple grapes inhibit platelet function and enhance nitric oxide release. Circulation 103:2792-8, 2001.
  • Frémont, L. Biological effects of resveratrol. Life Sciences 66: 663-673, 2000.
  • Gulati, O. Pycnogenol® in venous disorders: a review. European Bulletin of Drug Research 7: 1-13, 1999.
  • Hosseini, S., et al. Pycnogenol® in the management of asthma. Journal of Medicinal Food 4: 201-209, 2001. HHHh
  • Kohama, T., et al. The treatment of gynecological disorders with Pycnogenol®. European Bulletin of Drug Research 7: 30-32, 1999.
  • Kohama, T., et al. Analgesic efficacy of French maritime pine bark extract in dysmenorrhea. Journal of Reproductive Medicine 49: 828-32, 2004.
  • Liu, X., et al. Antidiabetic effect of Pycnogenol French maritime pine bark extract in patients with diabetes type II. Life Sci 75:2505-13, 2004.
  • Liu, X., et al. French maritime pine bark extract pycnogenol dose-dependently lowers glucose in type 2 diabetic patients. Diabetes Care 27: 839, 2004.
  • Manna, S., et al. Resveratrol suppresses TNF-Induced activation of nuclear transcription factors NF-kB, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. The Journal of Immunology 164: 6509-19, 2000.
  • Maritim, A., et al. Effects of pycnogenol treatment on oxidative stress in streptozotocin-induced diabetic rats. J Biochem Mol Toxicol 17:193-9, 2003.
  • Miyagi, Y., et al. Inhibition of human low-density lipoprotein oxidation by flavonoids in red wine and grape juice. Am J Cardiol 0:1627-31, 1997.
  • Monograph. Vaccinium myrtillus (bilberry). Altern Med Rev 6:500-4, 2001.
  • Murias M., et al. Resveratrol analogues as selective cyclooxygenase-2 inhibitors: synthesis and structure-activity relationship. Bioorg Med Chem 12: 5571-8, 2004.
  • Nuttall SL, Kendall MJ, Bombardelli E, Morazzoni P. An evaluation of the antioxidant activity of a standardized grape seed extract, Leucoselect. J Clin Pharm Ther 23: 385-89, 1998.
  • Ames, BN, et al. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci USA 90:7915-7922, 1993.
  • Bagchi, D, et al. Oxygen free radical scavenging abilities of vitamins C and E, and a grape seed proanthocyanidin extract in vitro. Res Commun Mol Pathol Pharmacol 95:179-89, 1997.


Isotonix® Multivitamin

  • Abbasi AA, Prasad AS, Rabbani P, DuMouchelle E. Experimental zinc deficiency in man. Effect on testicular function. J Lab Clin Med. 1980 Sep;96(3):544-50.
  • Abid M, Billington CJ, Nuttall FQ. Thyroid function and energy intake during weight gain following treatment of hyperthyroidism. J Am Coll Nutr. 1999 Apr;18(2):189-93.
  • Addison WLT, The use of sodium chloride, potassium chloride, sodium bromide and potassium bromide in cases of arterial hypertension which are amenable to potassium chloride. Can Med Assoc J. 1928; 18:281-285.
  • Allende LM, Corell A, Madrono A, Gongora R, Rodriguez-Gallego C, Lopez-Goyanes A, Rosal M, Arnaiz-Villena A. Retinol (vitamin A) is a cofactor in CD3-induced human T-lymphocyte activation. Immunology. 1997 Mar;90(3):388-96
  • Anderson RA. Effects of chromium on body composition and weight loss. Nutr Rev. 1998 Sep;56(9):266-70.
  • Arthur JR. Functional indicators of iodine and selenium status. Proc Nutr Soc. 1999 May;58(2):507-12.
  • Backstrom MC, Maki R, Kuusela AL, Sievanen H, Koivisto AM, Ikonen RS, Kouri T, Maki M. Randomised controlled trial of vitamin D supplementation on bone density and biochemical indices in preterm infants. Arch Dis Child Fetal Neonatal Ed. 1999 May;80(3):F161-6.
  • Bahadori B, Wallner S, Schneider H, Wascher TC, Toplak H. Effect of chromium yeast and chromium picolinate on body composition of obese, non-diabetic patients during and after a formula diet. Acta Med Austriaca. 1997;24(5):185-7.
  • Baly DL, Schneiderman JS, Garcia-Welsh AL. Effect of manganese deficiency on insulin binding, glucose transport and metabolism in rat adipocytes. J Nutr. 1990; 120:1075-1079.
  • Baron JA, Beach M, Mandel JS, et al. Calcium supplements for the prevention of colorectal adenomas. N Engl J Med 1999;340:101-107.
  • Baron JA, Tosteson TD, Wargovich MJ, et al. Calcium supplementation and rectal mucosal proliferation: a randomized controlled trial. J Natl Cancer Inst 1995;87:1303-1307.
  • Bates CJ. Vitamin A. Lancet. 1995; 345:31-35.
  • Baxter GF, Sumeray MS, Walker JM. Infant size and magnesium: insights into LIMIT-2 and ISIS-4 from experimental studies. Lancet. 1996; 348:1424-1426.
  • Behl C. Vitamin E and other antioxidants in neuroprotection. Int J Vitam Nutr Res. 1999 May;69(3):213-9. 4. Botterweck AA, van den Brandt PA, Goldbohm RA. Vitamins, carotenoids, dietary fiber, and the risk of gastric carcinoma: results from a prospective study after 6.3 years of follow-up. Cancer. 2000 Feb 15;88(4):737-48.
  • Bellamy MC, Gedney JA. Unrecognized iron deficiency in critical illness. Lancet. 1998; 352:1903.
  • Beutler E, Larsh SE, Gurney CW. Iron therapy in chronically fatigued nonanemic women: a double-blind study. Ann Intern Med. 1960; 52:378-394.
  • Bostick RM, Kushi LH, Wu Y, et al. Relation of calcium, vitamin D, and dairy food intake to ischemic heart disease mortality among postmenopausal women. Am J Epidemiol 1999;149:151-160.
  • Britton J, Pavord I, Richards K, et al. Dietary magnesium, lung function, wheezing, and airway hyper-reactivity in a random adult population sample. Lancet. 1994; 344:357-362.
  • Brown JE, Wahle KW Effect of fish-oil and vitamin E supplementation on lipid peroxidation and whole-blood aggregation in man. Clin Chim Acta. 1990 Dec 14;193(3):147-56.
  • Brun JF, Dieu-Cambrezy C, Charpiat A, Fons C, Fedou C, Micallef JP, Fussellier M, Bardet L, Orsetti A. Serum zinc in highly trained adolescent gymnasts. Biol Trace Elem Res. 1995 Jan-Mar;47(1-3):273-8.
  • Bruner AB, Joffe A, Duggan A, et al. Randomised study of cognitive effects of iron supplementation in non-anaemic iron-deficient adolescent girls. Lancet. 1996; 348:992-997.
  • Buchinger W, Lorenz-Wawschinek O, Semlitsch G, Langsteger W, Binter G, Bonelli RM, Eber O. Thyrotropin and thyroglobulin as an index of optimal iodine intake: correlation with iodine excretion of 39,913 euthyroid patients. Thyroid. 1997 Aug;7(4):593-7.
  • Butterfield DA, Koppal T, Subramaniam R, Yatin S. Vitamin E as an antioxidant/free radical scavenger against amyloid beta-peptide-induced oxidative stress in neocortical synaptosomal membranes and hippocampal neurons in culture: insights into Alzheimer's disease. Rev Neurosci. 1999;10(2):141-9
  • Cappuccio FP, MacGregor GA. Does potassium supplementation lower blood pressure? A meta-analysis of published trials. J Hypertens. 1991; 9:465-473.
  • Carlisle EM. Silicon as a trace nutrient. Sci Total Environ. 1988; 73:95-106.
  • Carlisle EM. The nutritional essentiality of silicon. Nutr Rev. 1982; 40:193-198.
  • Casscells W. Magnesium and myocardial infarction. Lancet. 1994; 343:807-809.
  • Christiansen CW, Rieder MA, Silverstein EL, Gencheff NE. Magnesium sulfate reduces myocardial infarct size when administered before but not after coronary reperfusion in a canine model. Circulation. 1995; 92:2617-2621.
  • Comstock GW, Alberg AJ, Huang HY, Wu K, Burke AE, Hoffman SC, Norkus EP, Gross M, Cutler RG, Morris JS, Spate VL, Helzlsouer KJ. The risk of developing lung cancer associated with antioxidants in the blood: ascorbic acid, carotenoids, alpha-tocopherol, selenium, and total peroxyl radical absorbing capacity. Cancer Epidemiol Biomarkers Prev. 1997 Nov;6(11):907-16.
  • Cooke MS, Evans MD, Podmore ID, et al. Novel repair action of vitamin C upon in vivo oxidative DNA damage. FEBS Lett. 1998; 439:363-367.
  • Cooney RV, Franke AA, Hankin JH, Custer LJ, Wilkens LR, Harwood PJ, Le Marchand L. Seasonal variations in plasma micronutrients and antioxidants. Cancer Epidemiol Biomarkers Prev. 1995 Apr-May;4(3):207-15.
  • Couzy F, Lafargue P, Guezennec CY. Zinc metabolism in the athlete: influence of training, nutrition and other factors. Int J Sports Med. 1990 Aug;11(4):263-6.
  • Dallman PR. Iron deficiency and the immune response. Am J Clin Nutr. 1987; 46:329-334.
  • Daudu PA, Kelley DS, Taylor PC, Burri BJ, Wu MM. Effect of a low beta-carotene diet on the immune functions of adult women. Am J Clin Nutr. 1994 Dec;60(6):969-72.
  • Dawson-Hughes B. Vitamin D and calcium: recommended intake for bone health. Osteoporos Int. 1998;8 Suppl 2:S30-4. 6. Feit JM. Calcium and vitamin D supplements for elderly patients. J Fam Pract. 1997 Dec;45(6):471-2.
  • de Lourdes Lima M, Cruz T, Carreiro Pousada J, et al. The effect of magnesium supplementation in increasing doses on the control of type 2 diabetes. Diabetes Care. 1998; 21:682-686.
  • de Valk B, Marx JJM. Iron, atherosclerosis, and ischemic heart disease. Arch Int Med. 1999; 159:1542-1548.
  • Dietary Reference Intakes for Calcium, Phosphorous, Magnesium, Vitamin D, and Fluoride. Washington, DC: National Academy Press; 1997.
  • Dorgan JF, Schatzkin A. Antioxidant micronutrients in cancer prevention. Hematol Oncol Clin North Am. 1991 Feb;5(1):43-68.
  • Dreon DM, Butterfield GE. Vitamin B6 utilization in active and inactive young men. Am J Clin Nutr. 1986 May;43(5):816-24.
  • Duffy SJ, Gokce N, Holbrook M, et al. Treatment of hypertension with ascorbic acid. Lancet. 1999; 354:2048-2049.
  • Durlach J, Durlach V, Bac P, et al. Magnesium and therapeutics. Magnes Res. 1994; 7:313-328.
  • Elisaf M, Merkouropoulos M, Tsianos EV. Siamopoulos KC. Pathogenetic mechanisms of hypomagnesemia in alcoholic patients. J Trace Elem Med Biol. 1995; 9:210-214.
  • Elitsur Y, Neace C, Liu X, Dosescu J, Moshier JA. Vitamin A and retinoic acids immunomodulation on human gut lymphocytes. Immunopharmacology. 1997 Jan;35(3):247-53.
  • Enstrom JE, Kanim LE, Klein MA. Vitamin C intake and mortality among a sample of the United States population. Epidemiology. 1992; 3:194-202.
  • Facchinetti F, Borella P, Sances G, et al. Oral magnesium successfully relieves premenstrual mood changes. Obstet Gynecol. 1991; 78:177-181.
  • Facchinetti F, Borella P, Sances G, et al. Oral magnesium successfully relieves premenstrual mood changes. Obstet Gynecol. 1991; 78:177-181.
  • Fairbanks VF. Iron in medicine and nutrition. In: Shils ME, Olson JA, Shike M, Ross AC, eds. Modern Nutrition in Health and Disease. Baltimore, MD: Williams and Wilkins; 1999:193-221.
  • Fang J, Madhavan S, Alderman MH. Dietary potassium intake and stroke mortality. Stroke. 2000; 31:1532-1537.
  • Fields M, Lewis CG. Starch diets high in iron can duplicate the severity of copper deficiency in rats fed fructose. J Med Food. 1998; 1:193-199.
  • Finch CA, Huebers H. Perspectives in iron metabolism. N Engl J Med. 1982; 306:1520-1528.
  • Flatt PR, Juntti-Berggren L, Berggren PO, Gould BJ, Swanston-Flatt SK. Failure of glucose tolerance factor-containing Brewer's yeast to ameliorate spontaneous diabetes in C57BL/KsJ DB/DB mice. Diabetes Res. 1989 Mar;10(3):147-51.
  • Futoryan T, Gilchrest BA. Retinoids and the skin. Nutr Rev. 1994; 52:299-310.
  • Gleeson M, Bishop NC. Elite athlete immunology: importance of nutrition. Int J Sports Med. 2000 May;21 Suppl 1:S44-50.
  • Grant KE, Chandler RM, Castle AL, Ivy JL. Chromium and exercise training: effect on obese women. Med Sci Sports Exerc. 1997 Aug;29(8):992-8.
  • Gullestad L, Dolva LO, Soyland E, et al. Oral magnesium supplementation improves metabolic variables and muscle strength in alcoholics. Alcohol Clin Exp Res. 1992; 16:986-990.
  • Guo WD, Chow WH, Zheng W, Li JY, Blot WJ. Diet, serum markers and breast cancer mortality in China. Jpn J Cancer Res. 1994 Jun;85(6):572-7.
  • Harris ED. Cellular copper transport and metabolism. Annu Rev Nutr. 2000; 20:291-310.
  • Harrison MD, Jones CE. Solioz M, Dameron CT. Intracellular copper routing: the role of copper chaperones. Trends Biochem Sci. 2000; 25:29-32.
  • Health & Medicine. (Statistical Data Included) American Fitness, July, 1999 Tannen RL. Effects of potassium on blood pressure control. Ann Intern Med. 1983; 98(part 2):773-780.
  • Hemila H, Douglas RM. Vitamin C and acute respiratory infections. Int J Tuberc Lung Dis. 1999; 3:756-761.
  • Hermans JJ, Fischer MA, Schiffers PM, Struijker-Boudier HA. High dietary potassium chloride intake augments rat renal mineralocorticoid receptor selectivity via 11beta-hydroxysteroid dehydrogenase. Biochim Biophys Acta. 1999; 1472:537-549.
  • Hermansen K. Diet, blood pressure and hypertension. Br J Nutr. 2000; 83 Supp1:S113-S119.
  • Hintze G, Kobberling J. Dietary iodine deficiency. Its consequences in the aged. Fortschr Med. 1992 Apr 10;110(10):163-6.
  • Huebers HA, Beguin Y, Pootrakul P, et al. Intact transferrin receptors in human plasma and their relation to erythropoiesis. Blood. 1990; 75:102-107.
  • Hughes K, Chua LH, Ong CN. Serum selenium in the general population of Singapore, 1993 to 1995. Ann Acad Med Singapore. 1998 Jul;27(4):520-3.
  • Hunt CD, Johnson PE, Herbel J, Mullen LK. Effects of dietary zinc depletion on seminal volume and zinc loss, serum testosterone concentrations, and sperm morphology in young men. Am J Clin Nutr. 1992 Jul;56(1):148-57.
  • Hwang J, Peterson H, Hodis HN, et al. Ascorbic acid enhances 17 beta-estradiol-mediated inhibition of oxidized low density lipoprotein formation. Atherosclerosis. 2000; 150:275-284.
  • Ishimitsu T, Tobian L, Sugimoto K, Everson T. High potassium diets reduce vascular and plasma lipid peroxides in stroke-prone spontaneously hypertensive rats. Clin Exp Hypertens. 1996; 18:659-673
  • Ishimitsu T, Tobian L, Sugimoto K, Lange JM. High potassium diets reduce macrophage adherence to vascular wall in stroke-prone spontaneously hypertensive rats. J Vasc Res. 1995; 32:406-412.
  • Ishimitsu T, Tobian L, Uehara Y, et al. Effect of high potassium diets on the vascular and renal prostaglandin system in stroke-prone spontaneously hypertensive rats. Prostaglandins Leukot Essent Fatty Acids. 1995; 53:255-260.
  • Ishimitsu T, Tobian L. High potassium diets reduce endothelial permeability in stroke-prone spontaneously hypertensive rats. Clin Exp Pharmacol Physiol. 1997; 23:241-245.
  • ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulfate in 58,050 patients with suspected acute myocardial infarction. Lancet. 1995; 345:669-685.
  • Jacobson SG, Cideciyan AV, Regunath G, et al. Night blindness in Sorsby's fundus dystrophy reversed by vitamin A. Nature Gen. 1995; 11:27-32.
  • Jin L, ChaoL, Chao J. Potassium supplement upregulates the expression of renal kalikrein and bradykinin B2 receptor in SHR. Am J Physiol. 1999; 276:F476-F484.
  • Johnson WT, Thomas AC. Copper deprivation potentiates oxidative stress in HL-60 cell mitochondria. Proc Soc Exp Biol Med. 1999; 221:147-152.
  • Kao WHL, Folsom AR, Nieto J, et al. Serum and dietary magnesium and the risk for type 2 diabetes mellitus (editorial). Arch. Int Med. 1999; 159:2151-2159.
  • Khaw K-T, Barrett-Conner E. Dietary potassium and stroke-associated mortality. N Engl J Med. 1987; 316:235-240.
  • Klevay LM. Cardiovascular disease from copper deficiency — a history. J Nutr. 2000; 130:489S-492S.
  • Klevay LM. Coronary heart disease: the zinc/copper hypothesis. Am J Clin Nutr. 1975; 28:764-774.
  • Knekt P, Jarvinen R, Seppanen R, Rissanen A, Aromaa A, Heinonen OP, Albanes D, Heinonen M, Pukkala E, Teppo L. Dietary antioxidants and the risk of lung cancer. Am J Epidemiol. 1991 Sep 1;134(5):471-9.
  • Krieger D, Krieger S, Jansen O, et al. Manganese and chronic hepatic encephalopathy. Lancet. 1995; 346:270-274.
  • Krishna GG, Miller E, Kapoor S. Increased blood pressure during potassium depletion in normotensive men. N Eng J Med. 1989; 320:1177-1182.
  • Krotkiewski M, Gudmundsson M, Backstrom P, Mandroukas K. Zinc and muscle strength and endurance. Acta Physiol Scand. 1982 Nov;116(3):309-11.
  • Kung AW, Janus ED. Thyroid dysfunction in ambulatory elderly Chinese subjects in an area of borderline iodine intake. Thyroid. 1996 Apr;6(2):111-4.
  • Lamberg L. Diet may affect skin cancer prevention. JAMA. 1998 May 13;279(18):1427-8.
  • Lee M-O, Han S-Y, Jiang S, et al. Differential effects of retinoic acid on growth and apoptosis in human colon cancer cell lines associated with the induction of retinoic acid receptor beta. Biochem Pharmacol. 2000; 59:485-496.
  • Lim R, Herzog WR. Magnesium for cardiac patients: is it a valuable treatment supplement? Contemp Int Med. 1998; 10:6-9.
  • Lin H, Young DB. Interactions between plasma potassium and epinephrine in coronary thrombosis in dogs. Circulation. 1994; 89:331-338.
  • Loeper J, Goy-Loeper J, Rozensztajn L, Fragny M. The antiatheromatous action of silicon. Atherosclerosis. 1979; 33:397-408.
  • LoPresti JS, Gray D, Nicoloff JT. Influence of fasting and refeeding on 3,3',5'-triiodothyronine metabolism in man. J Clin Endocrinol Metab. 1991 Jan;72(1):130-6.
  • Lucas MJ, Leveno KJ, Cunningham FG. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N Engl J Med. 1995; 333:201-205.
  • Lukaski HC. Magnesium, zinc, and chromium nutriture and physical activity. Am J Clin Nutr. 2000 Aug;72(2 Suppl):585S-93S.
  • Luoma P. Antioxidants, infections and environmental factors in health and disease in northern Finland. Int J Circumpolar Health. 1998 Jul;57(2-3):109-13.
  • Ma G, Young DB, Clower BR. Inverse relationship between potassium intake and coronary artery disease in the cholesterol-fed rabbit. Am J Hypertens. 1999; 12:821-825.
  • Manore MM. Effect of physical activity on thiamine, riboflavin, and vitamin B-6 requirements. Am J Clin Nutr. 2000 Aug;72(2 Suppl):598S-606S.
  • Martini LA. Magnesium supplementation and bone turnover. Nutr Rev. 1999; 57:227-229.
  • Mauskop A, Altura BM. Role of magnesium in the pathogenesis and treatment of migraines. Clin Neurosci. 1998; 5:24-27.
  • McCabe RD, Backarich MA, Srivastava K, Young DB. Potassium inhibits free radical formation. Hypertension. 1994; 24:77-82.

McCabe RD, Young DB. Potassium inhibits cultural vascular smooth muscle proliferation. Am J Hypertens. 1994; 7:346-350.

  • McCarty MF. Chromium and other insulin sensitizers may enhance glucagon secretion: implications for hypoglycemia and weight control. Med Hypotheses. 1996 Feb;46(2):77-80.
  • McDonald R, Keen CL. Iron, zinc and magnesium nutrition and athletic performance. Sports Med. 1988 Mar;5(3):171-84.
  • Meunier PJ. Calcium, vitamin D and vitamin K in the prevention of fractures due to osteoporosis. Osteoporos Int. 1999;9 Suppl 2:S48-52.
  • Miller ER 3rd, Appel LJ, Levander OA, Levine DM. The effect of antioxidant vitamin supplementation on traditional cardiovascular risk factors. J Cardiovasc Risk. 1997 Feb;4(1):19-24.
  • Miller JW. Vitamin E and memory: is it vascular protection? Nutr Rev. 2000 Apr;58(4):109-11. Bell L, Halstenson CE, Halstenson CJ, et al. Cholesterol-lowering effects of calcium carbonate in patients with mild to moderate hypercholesterolemia. Arch Intern Med. 1992; 152:2441-2444.
  • Morse AC, Beard JL, Jones BC. A genetic development model of iron deficiency: biological aspects. Proc Soc Exp Biol Med. 1999; 220:147-152.
  • Ness AR, Chee D, Elliot P. Vitamin C and blood pressure—an overview. J Hum Hypertens. 1997; 11:343-350.
  • Nielsen FH. Ultratrace minerals. In: Shils ME, Olson JA, Shike M, Ross AC, eds. Modern Nutrition in Health and Disease, 9th ed. Baltimore, MD: Williams and Wilkins; 1999:283-303.
  • Nielsen FH. Ultratrace minerals. In: Shils ME, Olson JA, Shike M, Ross AC, eds. Modern Nutrition in Health and Disease. 9th ed. Baltimore, MD: Williams and Wilkins; 199:283-303.
  • Nishi Y. Anemia and zinc deficiency in the athlete. J Am Coll Nutr. 1996 Aug;15(4):323-4.
  • Orchard TJ. Magnesium and type 2 diabetes mellitus (editorial). Arch Int Med. 1999; 159:2119-2120. Keen CL, Ensunsa JL, Watson MH, et al. Nutritional aspects of manganese from experimental studies. Neurotoxicol. 1999; 20:213-223.
  • Paul T, Meyers B, Witorsch RJ, Pino S, Chipkin S, Ingbar SH, Braverman LE. The effect of small increases in dietary iodine on thyroid function in euthyroid subjects. Metabolism. 1988 Feb;37(2):121-4.
  • Pauling L. Evolution and the need for ascorbic acid. Proc Natl Acad SciUSA. 1970; 67:1643-1648.
  • Pauling L. The significance of the evidence about ascorbic acid and the common cold. Proc Natl Acad SciUSA. 1971; 68:2678-2681.
  • Penn ND, Purkins L, Kelleher J, Heatley RV, Mascie-Taylor BH, Belfield PW. The effect of dietary supplementation with vitamins A, C and E on cell-mediated immune function in elderly long-stay patients: a randomized controlled trial. Age Ageing. 1991 May;20(3):169-74.
  • Podmore ID, Griffiths HR, Herbert KE, et al. Vitamin C exhibits pro-oxidant effects. Nature. 1998; 392:559.
  • Prasad AS, Cossack ZT. Neutrophil zinc: an indicator of zinc status in man. Trans Assoc Am Physicians. 1982;95:165-76.
  • Prasad AS. Zinc deficiency in human subjects. Prog Clin Biol Res. 1983;129:1-33.
  • Rayssiguier Y, Gueux E, Bussiere L, Mazur A. Copper deficiency increases the susceptibility of lipoproteins and tissues to peroxidation in rats. J Nutr. 1993; 123:1343-1348.
  • Reading SA. Chromium picolinate. J Fla Med Assoc. 1996 Jan;83(1):29-31.
  • Reinhardt W, Holtermann D, Benker G, Olbricht T, Jaspers C, Reinwein D. Effect of small doses of iodine on thyroid function during caloric restriction in normal subjects. Horm Res. 1993;39(3-4):132-7.
  • Rico H, Gallego-Lago JL, Hernandez ER, at al. Effect of silicon supplement on osteopenia induced by ovariectomy in rats. Calcif Tissue Int. 2000; 66:53-55.
  • Robuschi G, Emanuele R, Cavalli Sforza LT, Arsenio L, Strata A, Gnudi A, Roti E. Effect of iodine administration on thyroid function in diabetic patients. Acta Diabetol Lat. 1984 Oct-Dec;21(4):357-60.
  • Rock E, Mazur A, O'Connor JM, et al. The effect of copper supplementation on red blood cell oxidizability and plasma antioxidants in Middle-aged healthy volunteers. Free Rad Biol Med. 2000; 28:324-329.
  • Rokitzki L, Sagredos A, Keck E, Sauer B, Keul J. Assessment of vitamin B2 status in performance athletes of various types of sports. J Nutr Sci Vitaminol (Tokyo). 1994 Feb;40(1):11-22.
  • Ross AC, Stephensen CB. Vitamin A and retinoids in antiviral responses. FASEB J. 1996; 10:979-985.
  • Ross AC. Vitamin A and retinoids. In: Shils ME, Olson JA, Shike M, Ross AC, eds. Modern Nutrition in Health and Disease. 9th ed. Baltimore, MD: Williams and Wilkins; 1999:305-327.
  • Saari JT, Sahuschke DA. Cardiovascular effects of dietary copper deficiency. Biofactors. 1999; 10:359-375.
  • Schwarz K. A bound form of silicon in glycosaminoglycans and polyuronides. Proc Nat Acad Sci. 1973; 70:1608-1612.
  • Schwarz K. Silicon, fibre, and atherosclerosis. Lancet. 1977; 1:454-457.
  • Scrimshaw NS, San Giovanni JP. Synergism of nutrition, infection, and immunity: an overview. Am J Clin N. 1997; 66:464S-477S.
  • Semba RD. The role of vitamin A and related retinoids in immune function. Nutr Rev. 1998 Jan;56(1 Pt 2):S38-48.

Semba RD. Vitamin A and immunity to viral, bacterial and protozoan infections. Proc Nutr Soc. 1999 Aug;58(3):719-27.

  • Semba RD. Vitamin A, immunity, and infection. Clin Infect Dis. 1994 Sep;19(3):489-99.
  • Shephard RJ, Shek PN. Immunological hazards from nutritional imbalance in athletes. Exerc Immunol Rev. 1998;4:22-48.
  • Silva JE. Effects of iodine and iodine-containing compounds on thyroid function. Med Clin North Am. 1985 Sep;69(5):881-98.
  • Singh MA. Combined exercise and dietary intervention to optimize body composition in aging. Ann N Y Acad Sci. 1998 Nov 20;854:378-93.
  • Skaper SD, Fabris M, Ferrari V, et al. quercetin protects cutaneous tissue-associated cell types including sensory neurons from oxidative stress induced by glutathione depletion: cooperative effects of ascorbic acid. Free Rad Biol Med. 1997; 22:669-678.
  • Sohlenius-Sternbeck A-K, Appelkvist E-L, De Pierre JW. Effects of vitamin A deficiency on selected xenobiotic-metabolizing enzymes and defenses against oxidative stress in mouse liver. Biochem Pharmacol. 2000; 59:377-383.
  • Stahelin HB. Critical reappraisal of vitamins and trace minerals in nutritional support of cancer patients. Support Care Cancer. 1993 Nov;1(6):295-7.
  • Strause L, Saltman P, Glowacki J. The effect of deficiencies of manganese and copper on osteo-induction and on resorption of bone particles in rats. Calcif Tissue Int. 1987; 41:145-150
  • Suboticanec K, Stavljenic A, Bilic-Pesic L, Gorajscan M, Gorajscan D, Brubacher G, Buzina R. Nutritional status, grip strength, and immune function in institutionalized elderly. Int J Vitam Nutr Res. 1989;59(1):20-8.
  • Sugimoto K, Tobian L, Ishimutsu T, Lange JM. High potassium diets greatly increase growth-inhibiting agents in aortas of hypertensive rats. Hypertension. 1992; 19:749-752.
  • Sugimoto T, Tobian L, Ganguli MC. High potassium diets protect against dysfunction of endothelial cells in stroke-prone spontaneously hypertensive rats. Hypertension. 1988:11:579-585.
  • Suzuki M, Itokawa Y. Effects of thiamine supplementation on exercise-induced fatigue. Metab Brain Dis. 1996 Mar;11(1):95-106.
  • Taddei S, Virdis A, Ghiadoni L, et al. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. Circulation. 1998; 97:2222-2229.
  • Takahashi T, Fujimori K, Simon SL, Bechtner G, Edwards R, Trott KR. Thyroid nodules, thyroid function and dietary iodine in the Marshall islands. Int J Epidemiol. 1999 Aug;28(4):742-9.

Tannen RL. Effects of potassium on blood pressure control. Ann Intern Med. 1983; 98(part 2):773-780.

Taylor PR, Li B, Dawsey SM, Li JY, Yang CS, Guo W, Blot WJ. Prevention of esophageal cancer: the nutrition intervention trials in Linxian, China. Linxian Nutrition Intervention Trials Study Group. Cancer Res. 1994 Apr 1;54(7 Suppl):2029s-2031s.

  • Thilly CH, Swennen B, Bourdoux P, Ntambue K, Moreno-Reyes R, Gillies J, Vanderpas JB. The epidemiology of iodine-deficiency disorders in relation to goitrogenic factors and thyroid-stimulating-hormone regulation. Am J Clin Nutr. 1993 Feb;57(2 Suppl):267S-270S.
  • Thurnham DI. Micronutrients and immune function: some recent developments. J Clin Pathol. 1997 Nov;50(11):887-91.
  • Tobian L. Salt and hypertension. Lessons from animal models that relate to human hypertension. Hypertension. 1991; 17:152-158.
  • Toyama T, Kubuki Y, Suzuki M. Tsubouchi H. [Copper deficiency anemia and neutropenia secondary to total gastrectomy]. [Article in Japanese]. Rinsho Ketsueki. 2000; 41:441-443.
  • Trent LK, Thieding-Cancel D. Effects of chromium picolinate on body composition. J Sports Med Phys Fitness. 1995 Dec;35(4):273-80.
  • Turnlund Jr. Copper. In: Shils ME, Olson JA, Shike M. Ross AC, eds. Modern Nutrition in health and Disease, 9th ed. Baltimore, MD: Williams and Wilkins; 1999:241-252.
  • Underwood BA, Arthur P. The contribution of vitamin A to public health. FASEB J. 1996; 10:1040-1048
  • Uusitupa MI, Mykkanen L, Siitonen O, Laakso M, Sarlund H, Kolehmainen P, Rasanen T, Kumpulainen J, Pyorala K. Chromium supplementation in impaired glucose tolerance of elderly: effects on blood glucose, plasma insulin, C-peptide and lipid levels. Br J Nutr. 1992 Jul;68(1):209-16.
  • van den Brandt PA, Goldbohm RA, van 't Veer P, Bode P, Dorant E, Hermus RJ, Sturmans F. A prospective cohort study on selenium status and the risk of lung cancer. Cancer Res. 1993 Oct 15;53(20):4860-5.
  • van der Heyden JT, Docter R, van Toor H, Wilson JH, Hennemann G, Krenning EP. Effects of caloric deprivation on thyroid hormone tissue uptake and generation of low-T3 syndrome. Am J Physiol. 1986 Aug;251(2 Pt 1):E156-63.
  • Van Hooser JP, Aleman TS, He Y-G, et al. Rapid restoration of visual pigment and function with oral retinoid in a mouse model of childhood blindness. Proc Natl Acad Sci USA. 2000; 97:8623-8628.
  • Vatassery GT, Bauer T, Dysken M. High doses of vitamin E in the treatment of disorders of the central nervous system in the aged. Am J Clin Nutr. 1999 Nov;70(5):793-801.
  • Vatassery GT. Vitamin E and other endogenous antioxidants in the central nervous system. Geriatrics. 1998 Sep;53 Suppl 1:S25-7.
  • Waggoner DJ, Bartnikas TB, Gitlin JD. The role of copper in neurodegenerative disease. Neurobiology of Disease. 1999; 6:221-230.
  • Wahl R, Pilz-Mittenburg KW, Heer W, Kallee E. Iodine content in diet and excretion of iodine in urine. Z Ernahrungswiss. 1995 Dec;34(4):269-76.
  • Walker LS, Bemben MG, Bemben DA, Knehans AW. Chromium picolinate effects on body composition and muscular performance in wrestlers. Med Sci Sports Exerc. 1998 Dec;30(12):1730-7.
  • Wang Y, Mackenzie B, Tsukaguchi H, et al. Human vitamin C (L-ascorbic acid) transporter SVCT1. Biochem Biophys Res Commun. 2000; 267:488-494.
  • Wargovich MJ, Eng VWS, Newmark HL. Calcium inhibits the damaging and compensatory proliferative effects of fatty acids on mouse colon epithelium. Cancer Lett. 1984; 23:253-258.
  • Weaver CM, Heaney RP. Calcium. In: Shils ME, Olson JA, Shike M, Ross AC, eds. Modern Nutrition in Health and Disease. 9th ed. Baltimore, MD: Williams and Wilkins; 1999:141-155.
  • West KP Jr, Pokhrel RP, Katz J, et al. Efficacy of vitamin A in reducing preschool child mortality in Nepal. Lancet. 1991; 338:67-71.
  • West SG, Light KC, Hinderliter AL, et al. Potassium supplementation induces beneficial cardiovascular changes during rest and stress in salt sensitive individuals. Health Psychol. 1999; 18:229-240.
  • Whelton PK, He J, Cutler JA, et al. Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical triglyceride trials. JAMA. 1997; 277:1624-1632.
  • Wolf RL, Cauley JA, Baker CE, et al. Factors associated with calcium absorption efficiency in pre- and perimenopausal women. Am J Clin Nutr. 2000; 72:466-471.
  • Young DB, Lin H, McCabe RD. Potassium's cardiovascular protective mechanisms. Am J Physiol. 1995; 268:R825-R837.
  • Young DB, Ma G. Vascular protective effects of potassium. Semin Nephrol. 1999; 19:477-486.
  • Zemel MB, Shi H, Greer B, et al. Regulation of adiposity by dietary calcium. FASEB J. 2000; 14:1132-1138.

Zhou B, Wang T, Sun G, Guan P, Wu JM. A case-control study of the relationship between dietary factors and risk of lung cancer in women of Shenyang, China. Oncol Rep. 1999 Jan-Feb;6(1):139-43.

  • Zhou MS, Nishida Y, Yoneyama H, et al. Potassium supplementation increases sodium excretion in hypertensive Dahl rats. Clin Exp Hypertens.


Isotonix® Activated B-Complex

  • Benton D., et al. Thiamine supplementation for mood and cognitive functioning. Psychopharmacology. 129(1):66-71, 1997.
  • Benton, D., et al. The effects of nutrients on mood. Public Health Nutr. 2(3A):403-409, 1999.
  • Bhagavan, H. N., et al. The effect of pyridoxine hydrochloride on blood serotonin and pyridoxal phosphate contents in hyperactive children. Pediatrics. 55(3):437-441, 1975.
  • Bronstrup A, Hages M, Prinz-Langenohl R, Pietrzik K. Effects of folic acid and
  • Bryan, J., et al. Associations between dietary intake of folate and vitamins B-12 and B-6 and self-reported cognitive function and psychological well-being in Australian men and women in midlife. J Nutr Health Aging. 8(4):226-232, 2004.
  • Bryan, J., et al. Short-term folate, vitamin B-12 or vitamin B-6 supplementation slightly affects memory performance but not mood in women of various ages. Journal of Nutrition. 132(6):1345-1356, 2002.
  • combinations of folic acid and vitamin B12 on plasma homocysteine concentrations in healthy young women. Am J Clin Nutr 68:1104-10, 1998.
  • Coppen, A., et al. Plasma folate and affective morbidity during long-term lithium therapy. Br J Psychiatry. 141:87-89, 1982.
  • Cummings, P. M., et al. Effect of folic acid and antioxidant vitamins on endothelial dysfunction in patients with coronary artery disease. J Am Coll Cardiol. 36:758-765, 2000.
  • Dharmarajan, T. S., et al. Vitamin B12 deficiency. Recognizing subtle symptoms in older adults. Geriatrics. 58(3):30-34, 2003.
  • Doshi, S. N., et al. Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering. Circulation. 105(1):22-26, 2002.
  • Duthie, S. J., et al. Homocysteine, B vitamin status, and cognitive function in the elderly. American Journal of Clinical Nutrition. 75(5):908-913, 2002.
  • Friso, S., et al. Low plasma vitamin B-6 concentrations and modulation of coronary artery disease risk. Am J Clin Nutr. 79(6):992-998, 2004.
  • Grant, J. E., et al. Analysis of dietary intake and selected nutrient concentrations in patients with chronic fatigue syndrome. J Am Diet Assoc. 96(4):383-386, 1996.
  • Hartvig, P., et al. Pyridoxine effect on synthesis rate of serotonin in the monkey brain measured with position emission tomography. Neural Trans. 102:91-97, 1995.
  • Heap, L. C., et al. Vitamin B status in patients with chronic fatigue syndrome. J R Soc Med. 92(4):183-185, 1999.
  • Heseker, H., et al. Psychological disorders as early symptoms of a mild-to-moderate vitamin deficiency. Ann N Y Acad Sci. 669:352-357, 1992.
  • Jacobson, W., et al. Serum folate and chronic fatigue syndrome. Neurology. 43:2645-2647, 1993.
  • Kelly, G. S. Nutritional and botanical interventions to assist with the adaptation to stress. Alternative Medicine Review.4(4):249-265, 1999.
  • Litoff, D., et al. Effects of pantothenic acid supplementation on human exercise. Med Sci Sport Exercise., 17(Supplement):287, 1985.
  • Osada, K., et al. Experimental study of fatigue provoked by biotin deficiency in mice. Int J Vitam Nutr Res. 74(5):334-340, 2004.
  • Quadri, P., et al. Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia. Am J Clin Nutr. 80(1):114-122, 2004.
  • Riggs, K. M., et al. Relations of vitamin B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the Normative Aging Study. American Journal of Clinical Nutrition. 63(3):306-314, 1996.
  • Van den Berg M., et al. Combined vitamin B-6 plus folic acid therapy in young patients with arteriosclerosis and hyperhomocysteinemia. Journal Vascular Surgery. 20(6):933-940, 1994.
  • van Oort FV, Melse-Boonstra A, Brouwer IA, et al. Folic acid and reduction of plasma homocysteine concentrations in older adults: a dose-response study. 77:1318-23, 2003.
  • Vargiu, R., et al. Enhancement of muscular performance by a coformulation of propionyl-L-carnitine, coenzyme Q(10), nicotinamide, riboflavin and pantothenic acid in the rat. Physiol Behav. 76(2):257-63, 2002.
  • Wald DS, Bishop L, Wald NJ, et al. Randomized trial of folic acid supplementation and serum homocysteine levels. Arch Intern Med 61:695-700, 2001.
  • Werbach, M. R. Nutritional strategies for treating chronic fatigue syndrome. Alternative Medicine Review. 5(2):93-108, 2000.
  • Woo, K. S., et al. Long-term improvement in homocysteine levels and arterial endothelial function after 1-year folic acid supplementation. American Journal of Medicine. 112(7):535-539, 2002.


Isotonix® Calcium Plus

  • Allender PS, Cutler JA, Follman D, et al. Dietary calcium and blood pressure: meta—analysis of randomized clinical trials. Ann Intern Med. 1996; 124:825-831.
  • Altura BM, Altura BT. Role of magnesium and calcium in alcohol-induced hypertension and strokes as probed by in vivo television microscopy, digital image microscopy, optical spectroscopy, 31P-NMR, spectroscopy and a unique magnesium ion-selective electrode. Alcohol Clin Exp Res. 1994; 18:1057-1068.
  • Baly DL, Schneiderman JS, Garcia-Welsh AL. Effect of manganese deficiency on insulin binding, glucose transport and metabolism in rat adipocytes. J Nutr. 1990; 120:1075-1079.
  • Baron JA, Beach M, Mandel JS, et al. Calcium supplements for the prevention of colorectal adenomas. N Engl J Med 1999;340:101-107.
  • Baron JA, Tosteson TD, Wargovich MJ, et al. Calcium supplementation and rectal mucosal proliferation: a randomized controlled trial. J Natl Cancer Inst 1995;87:1303-1307.
  • Baxter GF, Sumeray MS, Walker JM. Infant size and magnesium: insights into LIMIT-2 and ISIS-4 from experimental studies. Lancet. 1996; 348:1424-1426.
  • Beattie JH, Peace HS. The influence of a low-boron diet and boron supplementation on bone, major mineral and sex steroid metabolism in postmenopausal women. Br J Nutr. 1993 May;69(3):871-84.
  • Bell L, Halstenson CE, Halstenson CJ, et al. Cholesterol-lowering effects of calcium carbonate in patients with mild to moderate hypercholesterolemia. Arch Intern Med. 1992; 152:2441-2444.
  • Bostick RM, Kushi LH, Wu Y, et al. Relation of calcium, vitamin D, and dairy food intake to ischemic heart disease mortality among postmenopausal women. Am J Epidemiol 1999;149:151-160.
  • Britton J, Pavord I, Richards K, et al. Dietary magnesium, lung function, wheezing, and airway hyper-reactivity in a random adult population sample. Lancet. 1994; 344:357-362.
  • Buckley LM, Leib ES, Cartularo KS, et al. Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. Ann Intern Med. 1996; 125:961-968.
  • Casscells W. Magnesium and myocardial infarction. Lancet. 1994; 343:807-809.
  • Christiansen CW, Rieder MA, Silverstein EL, Gencheff NE. Magnesium sulfate reduces myocardial infarct size when administered before but not after coronary reperfusion in a canine model. Circulation. 1995; 92:2617-2621.
  • Christin Marandino, Vegetarian Times, August 1998
  • Curhan GC, Willett WC, Speizer FE, et al. Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk of kidney stones in women. Ann Intern Med. 1997; 126:497-504.
  • Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium and vitamin D supplementation on bone density on men and women 65 years of age and older. N Engl J Med. 1997; 337:670-676.
  • de Lourdes Lima M, Cruz T, Carreiro Pousada J, et al. The effect of magnesium supplementation in increasing doses on the control of type 2 diabetes. Diabetes Care. 1998; 21:682-686.
  • Dietary Reference Intakes for Calcium, Phosphorous, Magnesium, Vitamin D, and Fluoride. Washington, DC: National Academy Press; 1997.
  • Durlach J, Durlach V, Bac P, et al. Magnesium and therapeutics. Magnes Res. 1994; 7:313-328.
  • Elisaf M, Merkouropoulos M, Tsianos EV. Siamopoulos KC. Pathogenetic mechanisms of hypomagnesemia in alcoholic patients. J Trace Elem Med Biol. 1995; 9:210-214.
  • Facchinetti F, Borella P, Sances G, et al. Oral magnesium successfully relieves premenstrual mood changes. Obstet Gynecol. 1991; 78:177-181.
  • Garland CF, Garland FC, Gorham ED. Calcium and vitamin D. Their potential roles in colon and breast cancer prevention. Ann NY Acad Sci. 1999; 889:107-119.
  • Gong H, Amemiya T. Optic nerve changes in manganese-deficient rats. Exp Eye Res. 1999; 68:313-320.
  • Gullestad L, Dolva LO, Soyland E, et al. Oral magnesium supplementation improves metabolic variables and muscle strength in alcoholics. Alcohol Clin Exp Res. 1992; 16:986-990.
  • Health & Medicine. (Statistical Data Included) American Fitness, July, 1999 Tannen RL. Effects of potassium on blood pressure control. Ann Intern Med. 1983; 98(part 2):773-780.
  • Heaney RP. Calcium, dairy products and osteoporosis. J Am Coll Nutr. 2000; 19(2 Suppl):83S-99S.
  • Hussain S, Ali SF. Manganese scavenges superoxide and hydroxyl radicals: an in vitro study in rats. Neuroscience Letters. 1999; 261:21-24.
  • ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulfate in 58,050 patients with suspected acute myocardial infarction. Lancet. 1995; 345:669-685.

Jorde R, Sundsfjord J, Haug E, et al. Relation between low calcium intake, parathyroid hormone, and blood pressure. Hypertension 2000;35:1154-1159.

Kao WHL, Folsom AR, Nieto J, et al. Serum and dietary magnesium and the risk for type 2 diabetes mellitus (editorial). Arch. Int Med. 1999; 159:2151-2159.

  • Keen CL, Ensunsa JL, Watson MH, et al. Nutritional aspects of manganese from experimental studies. Neurotoxicol. 1999; 20:213-223.
  • Krieger D, Krieger S, Jansen O, et al. Manganese and chronic hepatic encephalopathy. Lancet. 1995; 346:270-274.
  • Lim R, Herzog WR. Magnesium for cardiac patients: is it a valuable treatment supplement? Contemp Int Med. 1998; 10:6-9.
  • Lipkin M, Newmark H. Effect of added dietary calcium on colonic epithelial-cell proliferation in subjects at high risk for familial colonic cancer. N Engl J Med. 1985; 313:1381-1384.
  • Lucas MJ, Leveno KJ, Cunningham FG. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N Engl J Med. 1995; 333:201-205.
  • Martini LA. Magnesium supplementation and bone turnover. Nutr Rev. 1999; 57:227-229.
  • Mauskop A, Altura BM. Role of magnesium in the pathogenesis and treatment of migraines. Clin Neurosci. 1998; 5:24-27.
  • Naghii MR, Wall PM, Samman S. The boron content of selected foods and the estimation of its daily intake among free-living subjects. J Am Coll Nutr. 1996 Dec;15(6):614-9.
  • Newnham RE. Essentiality of boron for healthy bones and joints. Environ Health Perspect. 1994;102:83-85
  • Nielsen FH. Studies on the relationship between boron and magnesium which possibly affects the formation and maintenance of bones. Magnes Trace Elem. 1990;9:61-69
  • Nielsen FH. Ultratrace minerals. In: Shils ME, Olson JA, Shike M, Ross AC, eds. Modern Nutrition in Health and Disease, 9th ed. Baltimore, MD: Williams and Wilkins; 1999:283-303.
  • Oginni LM, Sharp CA, Worsfold M, et al. Healing of rickets after calcium supplementation. Lancet. 1999; 353:296-297.
  • Orchard TJ. Magnesium and type 2 diabetes mellitus (editorial). Arch Int Med. 1999; 159:2119-2120.
  • Paolisso G, Sgamabato S, Pizza G, et al. Improved insulin response and action by chronic magnesium administration in aged NIDDM. Diabetes Care. 1989; 12:265-269.
  • Peikert A, Wilimzig C, Kohne-Volland R. Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia. 1996; 16:257-263.
  • Penland J.G. The importance of boron nutrition for brain and psychological function. Biol Trace Elem Res. 1998; 66:299-317.
  • Recker RR. Calcium absorption and achlorhydria. N Engl J Med. 1985; 313:70-73. Reid IR, Ames RW, Evans MC, et al. Effect of calcium supplementation on bone loss in postmenopausal women. N Engl J Med. 1993; 328:460-464.
  • Rivlin RS. Magnesium deficiency and alcohol intake: mechanisms, clinical significance and possible relation to cancer development (a review). J Am Coll Nutr. 1994; 13:416-423.
  • Roberts JM. Magnesium for preeclampsia and eclampsia. N Engl J Med. 1995; 333:250-251.
  • Roffe C, Fletcher S, Woods KL. Investigation of the effects of intravenous magnesium sulphate on cardiac rhythm in acute myocardial infarction. Br Heart J. 1994; 71:141-145.
  • Saris N-EL, Mervaala E, Karppanen H, et al. Magnesium. An update on physiological, clinical and analytical aspects (review). Clinica Chimica Acta. 2000; 294:1-26.

Shils ME. Magnesium. In: Shils M, Olson JA, Shike M, Ross AC, eds. Modern Nutrition in Health and Disease. 9th ed. Baltimore, MD: Williams and Wilkins; 1999:169-192.

  • Singh MA. Combined exercise and dietary intervention to optimize body composition in aging. Ann N Y Acad Sci. 1998 Nov 20;854:378-93.
  • Singh N, Singh PN, Hershman JM. Effect of calcium carbonate on the absorption of levothyroxine. JAMA. 2000; 283:2822-2825.
  • Sojka JE. Magnesium supplementation and osteoporosis. Nutr Rev. 1995; 53:71-80.
  • Strause L, Saltman P, Glowacki J. The effect of deficiencies of manganese and copper on osteo-induction and on resorption of bone particles in rats. Calcif Tissue Int. 1987; 41:145-150
  • Strause L, Saltman P, Smith KT, et al. Spinal bone loss in postmenopausal women supplemented with calcium and trace minerals. J Nutr. 1994; 124:1060-1064.

Sutherland B, Strong P, King JC. Determining human dietary requirements for boron. Biol Trace Elem Res. 1998 Winter;66(1-3):193-204.

  • Talbot JR, Guardo P, Seccia S, et al. Calcium bioavailability and parathyroid hormone acute changes after oral intake of dairy and nondairy products in healthy volunteers. Osteoporosis Int. 1999; 10:137-142.
  • Tobian L. Salt and hypertension. Lessons from animal models that relate to human hypertension. Hypertension. 1991; 17:152-158.
  • Tosiello L. Hypomagnesemia and diabetes mellitus. A review of clinical implications. Arch Intern Med. 1998; 156:1143-1148.
  • Volpe SL, Taper LJ, Meacham S. The relationship between boron and magnesium status and bone mineral density in the human: a review. Magnes Res. 1993;6:291-296
  • Wargovich MJ, Eng VWS, Newmark HL. Calcium inhibits the damaging and compensatory proliferative effects of fatty acids on mouse colon epithelium. Cancer Lett. 1984; 23:253-258.
  • Weaver CM, Heaney RP. Calcium. In: Shils ME, Olson JA, Shike M, Ross AC, eds. Modern Nutrition in Health and Disease. 9th ed. Baltimore, MD: Williams and Wilkins; 1999:141-155.
  • Wolf RL, Cauley JA, Baker CE, et al. Factors associated with calcium absorption efficiency in pre- and perimenopausal women. Am J Clin Nutr. 2000; 72:466-471.
  • Woods KL, Fletcher S. Long-term outcome after intravenous magnesium sulphate in suspected acute myocardial infarction: the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet. 1994; 343:816-819.
  • Zemel MB, Shi H, Greer B, et al. Regulation of adiposity by dietary calcium. FASEB J. 2000; 14:1132-1138.


TLS產品評論


目前没有對此產品的評價。
發表評論